Literature DB >> 16110924

Analysis of recombinant group B streptococcal protein ScaAB and evaluation of its immunogenicity.

E I Vorobieva1, L F Meringova, G F Leontieva, K B Grabovskaya, A N Suvorov.   

Abstract

Group B streptococcal (GBS) gene encoding the putative lipoprotein and adherence factor ScaAB was cloned and expressed in E. coli. Recombinant ScaAB protein was isolated. Signal sequence of ScaAB was found to be cleaved in the E. coli host. ScaAB recombinant protein was immunogenic in mice and antibodies against this protein were discovered in mice sera after GBS infection. The perspectives of the use of ScaAB protein in GBS vaccine are discussed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16110924     DOI： 10.1007/BF02931468

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.629


  20 in total

1.  Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Authors:  D E Briles; E Ades; J C Paton; J S Sampson; G M Carlone; R C Huebner; A Virolainen; E Swiatlo; S K Hollingshead
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Construction of recombinant polypeptides based on beta antigen C (Bac) protein & their usage for protection against group B streptococcal infection.

Authors:  A Suvorov; I Ustinovitch; L Meringova; K Grabovskaya; G Leontieva; E Vorobieva; A Totolian
Journal:  Indian J Med Res       Date:  2004-05       Impact factor: 2.375

3.  The crystal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and a novel structure for a putative ABC-type binding protein.

Authors:  M C Lawrence; P A Pilling; V C Epa; A M Berry; A D Ogunniyi; J C Paton
Journal:  Structure       Date:  1998-12-15       Impact factor: 5.006

4.  The fimA locus of Streptococcus parasanguis encodes an ATP-binding membrane transport system.

Authors:  J C Fenno; A Shaikh; G Spatafora; P Fives-Taylor
Journal:  Mol Microbiol       Date:  1995-03       Impact factor: 3.501

5.  Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group.

Authors:  J A Regan; M A Klebanoff; R P Nugent; D A Eschenbach; W C Blackwelder; Y Lou; R S Gibbs; P J Rettig; D H Martin; R Edelman
Journal:  Am J Obstet Gynecol       Date:  1996-04       Impact factor: 8.661

Review 6.  Cell surface protein receptors in oral streptococci.

Authors:  H F Jenkinson
Journal:  FEMS Microbiol Lett       Date:  1994-08-15       Impact factor: 2.742

7.  Characterization of a complex restriction-modification system detected in Staphylococcus aureus and Streptococcus agalactiae strains isolated from infections of domestic animals.

Authors:  A Godány; G Bukovská; J Farkasovská; Z Brnáková; A Dmitriev; E Tkáciková; T Ayele; I Mikula
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

8.  Genetic heterogeneity of the pathogenic potentials of human and bovine group B streptococci.

Authors:  A Dmitriev; E Shakleina; L Tkáciková; I Mikula; A Totolian
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

9.  Identification of LpeA, a PsaA-like membrane protein that promotes cell entry by Listeria monocytogenes.

Authors:  Hélène Réglier-Poupet; Elisabeth Pellegrini; Alain Charbit; Patrick Berche
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Nucleotide sequence of the Streptococcus gordonii PK488 coaggregation adhesin gene, scaA, and ATP-binding cassette.

Authors:  P E Kolenbrander; R N Andersen; N Ganeshkumar
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441
View more
  5 in total

1.  Development of specific and rapid detection of bacterial pathogens in dairy products by PCR.

Authors:  M Chotár; B Vidová; A Godány
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

2.  Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides.

Authors:  Yulia A Desheva; Galina F Leontieva; Tatiana A Kramskaya; Tatiana A Smolonogina; Kornelia B Grabovskaya; Irina V Kiseleva; Larisa G Rudenko; Alexander N Suvorov
Journal:  Open Microbiol J       Date:  2016-10-31

3.  Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides.

Authors:  Yulia A Desheva; Galina F Leontieva; Tatiana A Kramskaya; Tatiana A Smolonogina; Kornelia B Grabovskaya; Galina O Landgraf; Vadim E Karev; Alexander N Suvorov; Larisa G Rudenko
Journal:  Virology (Auckl)       Date:  2017-06-06

4.  Mucosal vaccine based on attenuated influenza virus and the group B Streptococcus recombinant peptides protected mice from influenza and S. pneumoniae infections.

Authors:  Yulia Desheva; Galina Leontieva; Tatiana Kramskaya; Kornelia B Grabovskaya; Vadim Karev; Andery Mamontov; Petr Nazarov; Alexander Suvorov
Journal:  PLoS One       Date:  2019-06-25       Impact factor: 3.240

5.  Development of experimental GBS vaccine for mucosal immunization.

Authors:  T Gupalova; G Leontieva; T Kramskaya; K Grabovskaya; E Bormotova; D Korjevski; A Suvorov
Journal:  PLoS One       Date:  2018-05-04       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.